Outcome of medulloblastoma in children treated with reduced-dose radiation therapy plus adjuvant chemotherapy

• المؤلفون الرئيسيون: Nongnuch Sirachainan, Issarang Nuchprayoon, Pattra Thanarattanakorn, Samart Pakakasama, Apasri Lusawat, Anannit Visudibhan, Mantana Dhanachai, Noppadol Larbcharoensub, Jiraporn Amornfa, Kanchana Shotelersuk, Kamornwan Katanyuwong, Saipin Tangkaratt, Suradej Hongeng
• التنسيق: دورية
• منشور في: 2018
• الموضوعات: Medicine; Neuroscience
• الوصول للمادة أونلاين: https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=79952186468&origin=inward; http://cmuir.cmu.ac.th/jspui/handle/6653943832/50251

Medulloblastoma is the most common malignant brain tumor in children. Post-surgical craniospinal irradiation (CSI; 30-36 Gy) plus local boost radiation therapy (RT; 54-56 Gy) is a standard treatment for children with medulloblastoma who are over 3 years old, resulting in a 5-year overall survival (O...